肺癌的生存率:治疗和预防的潜在目标 - - 叙述性综述
Akhil Goud Pachimatla1, Robert Fenstermaker2,3, Michael Ciesielski2
1Department of Thoracic Surgery, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Translational lung cancer research
|March 18, 2024
概括
肺癌中的关键蛋白 Survivin 是一个有前途的生物标志物和治疗点. 基于幸存者的疫苗正在开发中,以改善肺癌治疗和患者的生存率.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 幸存是一种多功能生物标志物,在增殖癌细胞中高度表达.
- 它的过度表达与晚期肺癌和治疗耐药性有关.
- 幸存者调节亡,并参与瘤血管化和转移.
研究的目的:
- 审查肺癌中与生存相关的分子机制.
- 为了检查在肺癌治疗中生存的治疗潜力.
- 讨论幸存者在预后,治疗反应和未来疫苗开发中的作用.
主要方法:
- 在PubMed和美国国家医学图书馆的文献搜索.
- 关键词:呼吸道,肺,肺,支气管,NSLC,癌症,癌症,瘤,生存.
- 选了728个结果,研究了168个完整文本.
主要成果:
- 幸存者有助于肺癌的致癌,转移和耐治疗性.
- 基于免疫的疗法和以生存为中心的疫苗显示出有希望的针对性治疗.
- 核幸存者是高级非小细胞肺癌的生物标志物,并预测化学疗法耐药性.
结论:
- 基于Survivin的免疫疗法有可能预防肺癌并改善存活率.
- 目前针对生存者的治疗方法处于早期临床试验阶段 (I/II阶段).
- 对基于幸存者的免疫性治疗方法进行进一步的研究是有必要的.
相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...


